For help on how to get the results you want, see our search tips.
95 results
Keyword Remove keyword
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Referral type
Article 30 referrals Remove Article 30 referrals filter
-
List item
Referral: Zoloft
sertraline, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 27/03/2009, Last updated: 07/05/2009 -
List item
Referral: Tazocin
piperacillin, tazobactam, associated names: Tazobac, Tazocel, Tazonam, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 21/02/2011, Last updated: 19/11/2013 -
List item
Referral: Renitec
enalapril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/09/2002, EC decision date: 21/05/2003, Last updated: 02/12/2003 -
List item
Referral: Calcichew D3 mite
calcium, colecalciferol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004 -
List item
Referral: Diovan Comp
valsartan, hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/03/2009, EC decision date: 26/05/2009, Last updated: 11/06/2009 -
List item
Referral: Haldol and associated names
haloperidol, associated names: Aloperidin, Haldol-Janssen, Serenase, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/02/2017, EC decision date: 28/04/2017, Last updated: 05/05/2017 -
List item
Referral: Losec
omeprazole, associated names: Antra, Logastric, Losec Forte, Mopral, Omeprazen, Omeprazole, AstraZeneca, Zoltum, Article 30 referrals
Status: European Commission final decision, opinion/position date: 20/01/2010, EC decision date: 10/06/2010, Last updated: 19/09/2011 -
List item
Referral: Etopophos
etoposide phosphate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/04/2017, EC decision date: 26/06/2017, Last updated: 14/07/2017 -
List item
Referral: Sandostatin LAR and associated names
ocreotide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2014, EC decision date: 26/06/2014, Last updated: 27/06/2014 -
List item
Referral: Glucophage/Glucophage Forte/Risidon/Dianben
metformin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/10/2000, EC decision date: 06/02/2001, Last updated: 07/02/2001 -
List item
Referral: Ecazide
captopril, hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/04/2002, EC decision date: 22/08/2002, Last updated: 19/09/2002 -
List item
Referral: Roaccutane
isotretinoin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/04/2003, EC decision date: 17/10/2003, Last updated: 02/12/2003 -
List item
Referral: Efexor
venlafaxine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 28/11/2008, Last updated: 18/12/2008 -
List item
Referral: Tritace
ramipril, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/12/2008, EC decision date: 06/03/2009, Last updated: 24/04/2009 -
List item
Referral: Flolan
epoprostenol, associated names: Epoprostenol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 08/08/2012, Last updated: 14/09/2012 -
List item
Referral: Lopid
gemfibrozil, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/03/2004, EC decision date: 29/07/2004, Last updated: 18/08/2004 -
List item
Referral: Scandonest and associated names
mepivacaine, associated names: Biocaine, Scandicaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 31/05/2018, EC decision date: 02/08/2018, Last updated: 07/08/2018 -
List item
Referral: Daivobet
calcipotriol, betamethasone, associated names: Dovobet, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/07/2010, EC decision date: 30/09/2010, Last updated: 26/04/2011 -
List item
Referral: Arimidex
anastrozole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 18/05/2011, Last updated: 27/07/2011 -
List item
Referral: Atacand Plus
candesartan, hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011 -
List item
Referral: Lipitor
atorvastatin, associated names: Atorvastatin, Atorvastatina Nostrum, Atorvastatina Parke-Davis, Atorvastatina Pharmacia, Cardyl, Edovin, Liprimar, Orbeos, Prevencor, Sortis, Tahor, Texzor, Torvast, Totalip, Xarator, Zarator, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 13/12/2010, Last updated: 10/04/2012 -
List item
Referral: Lamictal
lamotrigine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 23/07/2008, Last updated: 08/09/2008 -
List item
Referral: EMLA cream and associated names
lidocaine, prilocaine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/09/2014, EC decision date: 28/11/2014, Last updated: 15/01/2015 -
List item
Referral: Ciprofloxacin Bayer
ciprofloxacin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/07/2008, EC decision date: 07/10/2008, Last updated: 23/10/2008 -
List item
Referral: Sandimmun Neoral and associated names
ciclosporin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 31/10/2013, Last updated: 20/12/2013